NIP
OMIC

Nicholas Investment Partners’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Nicholas Investment Partners’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17,330
Closed -$3.28M – 212
2022
Q1 		$3.28M Sell
17,330
-6,704
-28% -$1.55M 0.23% 120
2021
Q4 		$8.34M Buy
24,034
+2,374
+11% +$920K 0.53% 73
2021
Q3 		$7.27M Buy
21,660
+669
+3% +$343K 0.53% 73
2021
Q2 		$17.3M Buy
+20,991
New +$16.3M 1.09% 32

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return